BLOGSCAN - Duplicate Publication about an SSRI

Courtesy Health Care Renewal  Sun, 09/28/2008 - 12:53

On the Clinical Psychology and Psychiatry Blog, the anonymous blogger described an interesting example of apparent dual publication on a selective serotonin reuptake inhibitor (SSRI) anti-depressant drug, duloxetine (Cymbalta, manufactured by Eli Lilly).

Important aspects of the story include how both articles draw conclusions that go well beyond the (same) data in their enthusiasm for the drug in question, and how the second article incorporated an author not found in the first, an author who...

Tags:

 

More related items

Antidepressants May Aid Stroke Rehabilitation
New research suggests that selective serotonin reuptake inhibitor (SSRI) antidepressants may help people move again after a stroke.

More Evidence for Suppression of Research: the Case...
We recently discussed the severe challenges to evidence-based medicine presented by manipulation and suppression of clinical research to serve vested interests. I recently (and unfortunately...

Attacking "Side Effects" with Logical Fallacies
Concerns about manipulation and suppression of the clinical research literature are gaining more traction. Recently, Alison Bass published Side Effects, a book that explored one of the more...

Burt's Bees Free Head to Toe Starter Kit

Lobe Wonder Ear Support Patches For Earrings,...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com